Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018146829) FAT EMULSION AND METHOD FOR PRODUCING SAME, METHOD FOR IMPROVING STABILITY OF FAT EMULSION, AND AGENT FOR IMPROVING STABILITY OF FAT EMULSION
Latest bibliographic data on file with the International Bureau    Submit observation
Pub. No.: WO/2018/146829 International Application No.: PCT/JP2017/017378
Publication Date: 16.08.2018 International Filing Date: 08.05.2017
IPC:
A61K 31/216 (2006.01) ,A61K 9/10 (2006.01) ,A61K 47/10 (2006.01) ,A61K 47/18 (2006.01) ,A61K 47/24 (2006.01) ,A61K 47/44 (2017.01) ,A61P 29/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
21
Esters, e.g. nitroglycerine, selenocyanates
215
of carboxylic acids
216
of acids having aromatic rings, e.g. benactizyne, clofibrate
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
08
containing oxygen
10
Alcohols; Phenols; Salts thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
16
containing nitrogen
18
Amines; Quaternary ammonium compounds
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
24
containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
44
Oils, fats or waxes according to more than one of groups A61K47/02-A61K47/42109
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29
Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
Applicants:
キユーピー株式会社 KEWPIE CORPORATION [JP/JP]; 東京都渋谷区渋谷１丁目４番１３号 4-13, Shibuya 1-chome, Shibuya-ku, Tokyo 1500002, JP
Inventors:
天野　陽平 AMANO Yohei; JP
Agent:
長谷川　芳樹 HASEGAWA Yoshiki; JP
清水　義憲 SHIMIZU Yoshinori; JP
坂西　俊明 BANZAI Toshiaki; JP
Priority Data:
2017-02037707.02.2017JP
Title (EN) FAT EMULSION AND METHOD FOR PRODUCING SAME, METHOD FOR IMPROVING STABILITY OF FAT EMULSION, AND AGENT FOR IMPROVING STABILITY OF FAT EMULSION
(FR) ÉMULSION DE GRAISSE AINSI QUE PROCÉDÉ DE FABRICATION DE CELLE-CI, PROCÉDÉ D’AMÉLIORATION DE STABILITÉ D’ÉMULSION DE GRAISSE, ET AGENT D’AMÉLIORATION DE STABILITÉ D’ÉMULSION DE GRAISSE
(JA) 脂肪乳剤、及びその製造方法、脂肪乳剤の安定性を向上させる方法、並びに脂肪乳剤の安定性向上剤
Abstract:
(EN) The present invention pertains to a fat emulsion which comprises flurbiprofen axetil, water, a vegetable oil, egg yolk lecithin, glycerol and histidine or a salt thereof, wherein the total content of histidine or a salt thereof is 0.025-0.19 part by mass inclusive, in terms of histidine, per part by mass of flurbiprofen axetil.
(FR) L’invention concerne une émulsion de graisse qui comprend un flurbiprofène axétil, une eau, une huile végétale, une lécithine de jaune d'œuf, une glycérine, et une histidine ou un sel de celle-ci. La teneur en histidine ou sel de celle-ci est supérieure ou égale à 0,025 partie en masse et inférieure ou égale à 0,19 partie en masse, au total en termes d’histidine, pour 1 partie en masse de flurbiprofène axétil.
(JA) 本発明は、フルルビプロフェンアキセチルと、水と、植物油と、卵黄レシチンと、グリセリンと、ヒスチジン又はその塩と、を含有し、ヒスチジン又はその塩の含有量が、フルルビプロフェンアキセチル１質量部に対して、ヒスチジン換算の総量で０．０２５質量部以上０．１９質量部以下である、脂肪乳剤に関する。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)